SEC EDGAR Filing Information

Form 10-K -- Annual report [Section 13 and 15(d), not S-K Item 405]

Period of Report: 2006-12-31
Filing Date Changed: 2007-02-27
Documents: 6

SEC Accession No.
0001193125-07-041180
Filing date: 2007-02-27
Accepted: 2007-02-27 17:15:24

Table of submitted documents:

Seq	Type	Document	Size	Description
1	10-K	d10k.htm	3021575	FORM 10-K FOR THE FISCAL YEAR ENDED DECEMBER 31, 2006
2	EX-21	dex21.htm	9309	SUBSIDIARIES
3	EX-31.1	dex311.htm	10609	CERTIFICATION OF CHIEF EXECUTIVE OFFICER (302)
4	EX-31.2	dex312.htm	10385	CERTIFICATION OF CHIEF FINANCIAL OFFICER (302)
5	EX-32.1	dex321.htm	3772	CERTIFICATION OF CHIEF EXECUTIVE OFFICER (906)
6	EX-32.2	dex322.htm	4063	CERTIFICATION OF CHIEF FINANCIAL OFFICER (906)

		0001193125-07-041180.txt	3061777	Complete submission text file

Filer Information:

US ONCOLOGY INC (Filer) (0000943061)
IRS No.: 841213501 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-26190 | Film No.: 07654220
SIC: 8093 Services-Specialty Outpatient Facilities, NEC

Assistant Director 1

Business Address
16825 NORTHCHASE DR
STE 1300
HOUSTON TX 77060
2818732674

Mailing Address

US Oncology Holdings, Inc. (Filer) (0001333191)
IRS No.: 200873619 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 333-126922 | Film No.: 07654219
SIC: 8060 Services-Hospitals

Assistant Director 1

Business Address
16825 NORTHCHASE DRIVE, SUITE 1300
HOUSTON TX 77060
(832) 601-8766

Mailing Address
16825 NORTHCHASE DRIVE, SUITE 1300
HOUSTON TX 77060